Envestnet Asset Management Inc. Has $15.42 Million Stake in Globe Life Inc. $GL

Envestnet Asset Management Inc. raised its holdings in shares of Globe Life Inc. (NYSE:GL) by 9.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 107,820 shares of the company’s stock after purchasing an additional 9,518 shares during the quarter. Envestnet Asset Management Inc. owned 0.13% of Globe Life worth $15,415,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Mather Group LLC. bought a new position in shares of Globe Life in the third quarter valued at approximately $28,000. CYBER HORNET ETFs LLC bought a new position in shares of Globe Life during the second quarter valued at about $28,000. Assetmark Inc. boosted its holdings in Globe Life by 777.8% during the second quarter. Assetmark Inc. now owns 237 shares of the company’s stock worth $29,000 after purchasing an additional 210 shares during the last quarter. MUFG Securities EMEA plc purchased a new position in Globe Life during the second quarter worth about $31,000. Finally, Quent Capital LLC bought a new stake in Globe Life in the 3rd quarter worth about $36,000. Institutional investors and hedge funds own 81.61% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on GL. TD Cowen restated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. JPMorgan Chase & Co. boosted their price objective on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Keefe, Bruyette & Woods raised their target price on Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a research report on Tuesday, October 28th. Weiss Ratings upgraded Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday. Finally, Morgan Stanley restated an “overweight” rating and set a $176.00 price target on shares of Globe Life in a research report on Monday, December 15th. Eight research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $171.00.

Globe Life Stock Performance

NYSE GL opened at $144.46 on Monday. The firm has a market cap of $11.50 billion, a price-to-earnings ratio of 10.26 and a beta of 0.47. The company has a 50-day simple moving average of $140.57 and a two-hundred day simple moving average of $138.39. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life Inc. has a 12-month low of $109.38 and a 12-month high of $152.71.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The firm had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the prior year, the business posted $3.14 EPS. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities analysts forecast that Globe Life Inc. will post 13.87 EPS for the current year.

Insider Buying and Selling at Globe Life

In other Globe Life news, Director Mark A. Blinn sold 1,750 shares of Globe Life stock in a transaction on Friday, February 6th. The stock was sold at an average price of $147.91, for a total transaction of $258,842.50. Following the completion of the transaction, the director owned 3,372 shares in the company, valued at approximately $498,752.52. The trade was a 34.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CMO Jennifer Allison Haworth sold 10,000 shares of Globe Life stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the completion of the transaction, the chief marketing officer directly owned 17,479 shares of the company’s stock, valued at $2,501,944.06. This trade represents a 36.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 51,129 shares of company stock valued at $7,414,035 in the last quarter. 1.97% of the stock is owned by insiders.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.